A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Remco de Brouwer, Wouter P. te Rijdt, Edgar T. Hoorntje, Ahmad Amin, Folkert W. Asselbergs, Moniek G.P.J. Cox, Jeroen F. van der Heijden, Hans Hillege, Jacco C. Karper, Belend Mahmoud, Peter van der Meer, Anton Oomen, Anneline S.J.M. te Riele, Herman H.W. Silljé, Hanno L. Tan, Jan Peter van Tintelen, Dirk J. van Veldhuisen, Berend Daan Westenbrink, Ans C.P. Wiesfeld, Tineke P. WillemsPaul A. van der Zwaag, Arthur A.M. Wilde, Rudolf A. de Boer*, Maarten P. van den Berg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Downloads (Pure)
Original languageEnglish
Pages (from-to)4284-4287
Number of pages4
JournalEuropean heart journal
Volume44
Issue number40
DOIs
Publication statusPublished - 21 Oct 2023

Keywords

  • Cardiomyopathy
  • Eplerenone
  • Fibrosis
  • Heart failure
  • Phospholamban
  • Randomized clinical trial

Cite this